AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Avazide MF 60mg/500mg Tablet XR

Prescription Icon
Prescription Required

Marketer

Alvio Pharma

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Avazide MF 60mg/500mg Tablet XR

Diabexe MF 60mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe MF 60mg/500mg ER Tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, risking complications like kidney impairment, vision loss, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices are integral to diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a rapid-acting glucose source, like sugary snacks or juice, to counteract hypoglycemia. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Avazide MF 60mg/500mg Tablet XR

Adult-onset diabetes

Major Benefits of Avazide MF 60mg/500mg Tablet XR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Avazide MF 60mg/500mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.

Common Side effects of Avazide MF 60mg/500mg Tablet XR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Avazide MF 60mg/500mg Tablet XR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Avazide MF 60mg/500mg Extended-Release tablet whole; do not chew, crush, or divide it. Consume this medication with a meal.

How Avazide MF 60mg/500mg Tablet XR works:

Extended-release Avazide MF tablets (60mg/500mg) contain gliclazide and metformin, two medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Avazide MF 60mg/500mg Tablet XR with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Avazide MF 60mg/500mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known dangers. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Avazide MF 60mg/500mg tablets are likely unsuitable for breastfeeding mothers. Scant clinical evidence indicates potential drug transfer via breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms manifest.

KidneyKidneyCAUTION

Patients with kidney impairment should use Avazide MF 60mg/500mg XR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Avazide MF 60mg/500mg XR tablets are contraindicated in those with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Avazide MF 60mg/500mg XR tablets cautiously, potentially requiring dosage modification. Consult a physician before use. A lower starting dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is unsuitable for those with severe liver disease.

What if you forget to take Avazide MF 60mg/500mg Tablet XR :

Should you forget to take your Avazide MF 60mg/500mg Tablet XR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Avazide MF 60mg/500mg Tablet XR

LabelValue
Potential for Dependence None.
Medication Classification Diabetes medication

FAQs on Avazide MF 60mg/500mg Tablet XR

Avazide MF 60mg/500mg extended-release tablets contain gliclazide and metformin, two medications used together to manage type 2 diabetes mellitus in adults. This dual therapy enhances blood sugar control when combined with a healthy diet and regular physical activity. Gliclazide functions by stimulating insulin secretion from the pancreas, while metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Avazide MF 60mg/500mg XR tablets are linked to several common adverse reactions. These include low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal discomfort, loose stools, headaches, and upper respiratory infections. While infrequent, serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Indeed, Avazide MF 60mg/500mg Extended-Release Tablets may induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is strongly recommended.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Avazide MF 60mg/500mg Tablet XR. Also termed Metformin-associated lactic acidosis (MALA), this rare complication is linked to metformin use. Risk factors include pre-existing kidney impairment, advanced age, and significant alcohol consumption. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia warrant immediate discontinuation of Avazide MF 60mg/500mg Tablet XR and prompt medical attention.
Prolonged use of Avazide MF 60mg/500mg Extended-Release tablets can lead to vitamin B12 deficiency. This is because the medication impairs the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia, neurological complications including paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive strategies proposed by some studies include annual supplemental vitamin B12 intake.
Patients with a documented allergy to Avazide MF 60mg/500mg Tablet XR's ingredients or inactive components should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol while taking Avazide MF 60mg/500mg Tablet XR is unsafe. This combination may reduce blood sugar to dangerously low levels (hypoglycemia) and heighten the risk of lactic acidosis.
The extended-release Avazide MF 60mg/500mg tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when coupled with a healthy diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Avazide MF 60mg/500mg extended-release tablets may cause frequent adverse reactions. These include low blood sugar, taste disturbances, queasiness, abdominal discomfort, loose stools, cephalalgia, and upper respiratory infections. Rare, yet potentially severe, adverse events such as lactic acidosis may also occur. Prolonged administration can result in vitamin B12 insufficiency.
Avazide MF 60mg/500mg Tablet XR can indeed lower blood sugar, leading to hypoglycemia. This can manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of taking Avazide MF 60mg/500mg Tablet XR. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse reaction is linked to metformin use. To mitigate risk, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, and heavy alcohol consumers. Symptoms such as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia warrant immediate discontinuation of Avazide MF 60mg/500mg Tablet XR and prompt medical attention.
Prolonged use of Avazide MF 60mg/500mg Extended-Release tablets can lead to vitamin B12 deficiency. This is because the medication impairs the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia, neurological complications such as tingling and numbness in the extremities, weakness, urinary dysfunction, cognitive changes, and impaired balance. Preventive measures, including supplemental vitamin B12 at least annually, have been proposed by some studies.
Patients with hypersensitivity to any Avazide MF 60mg/500mg Tablet XR ingredient or inactive component should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or metabolic acidosis, such as diabetic ketoacidosis.
Combining Avazide MF 60mg/500mg Tablet XR and alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and raises the likelihood of lactic acidosis.
Avazide MF 60mg/500mg Tab...
152
MRP 185
17% off